Navigation Links
BMP Sunstone to be Featured on SIG's 'China Healthcare On Call' Conference Call Series
Date:6/3/2009

PLYMOUTH MEETING, Pa., June 3 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP) ("BMP Sunstone" or the "Company") today announced that it will be featured on Susquehanna Financial Group's ("SIG") upcoming "China Healthcare On Call" conference call series to discuss the impact of China Healthcare Reform and the Company's growth strategy going forward. The series will be hosted by Ding Ding, Ph.D., SIG's senior analyst covering China's Healthcare Industry, and is scheduled to occur on Friday, June 5, at 10:00 am ET.

Please contact Integrated Corporate Relations at 203 682 8200, or contact your SIG sales person or email sfg.sales@sig.com for live conference call details.

A replay of the call will be made accessible at 800-332-6854, pin: 874155, until August 5, 2009.

About BMP Sunstone Corporation

BMP Sunstone Corporation is a specialty pharmaceutical company that is building a proprietary portfolio of branded pharmaceutical and healthcare products in China. Currently this portfolio includes eight products under exclusive multi-year licenses for China, primarily focused on women's health and pediatrics. The Company also owns Sunstone Pharmaceutical Co. Ltd., which manufactures leading pediatric and women's health products, including two of China's most recognized brands, "Hao Wawa" and "Confort," sold through approximately 120,000 pharmacies in China. The Company also provides pharmaceutical distribution services through its subsidiaries in Beijing and Shanghai, and through its affiliate, Guangzhou Pharmaceuticals Corp. The Company has its main office in Beijing, with a US office in Plymouth Meeting, PA. For more information, please visit http://www.bmpsunstone.com .


'/>"/>
SOURCE BMP Sunstone Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. BMP Sunstones Propess(R) Recommended as First Line Treatment By the Chinese Medical Association
2. BMP Sunstone to Report First Quarter 2008 Financial Results
3. BMP Sunstone Announces Participation in May Investor Conferences
4. BMP Sunstone Donates RMB 1.2 Million to Earthquake Relief
5. BMP Sunstone Reports First Quarter 2008 Financial Results
6. BMP Sunstone Announces Participation in June Investor Conferences
7. BMP Sunstone Announces Official Launch of Ferriprox in PRC
8. BMP Sunstone Completes Acquisition of Shanghai Rongheng Pharmaceutical Co., Ltd
9. BMP Sunstone Signs Letter of Intent to Acquire Shengda Pharmaceutical Co.
10. BMP Sunstone to Report Third Quarter 2008 Financial Results
11. BMP Sunstone Announces Exchange Offer of $10.7 Million of Outstanding Secured Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... Kenosha, Wisconsin (PRWEB) , ... December 07, 2016 , ... ... the extraordinary new MedMaster™ MPCNGX . The MPCNGX is a multi-function, sealed, LED ... the right amount of light where and when it’s needed. , A ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... to treat wrinkles and deep lines by smoothing and tightening the skin of ... techniques out there to address facial aging with very little downtime, Silhouette Instalift ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... a women growing up with a schizophrenic mother in a unique, personal perspective ... who specializes in treating trauma and addictive disorders at her private psychotherapy practice. ...
(Date:12/7/2016)... ... December 07, 2016 , ... In the early morning ... to an emergency medical call when he lost control of his patrol car. The ... from his vehicle, he was transported to Atlanta Medical Center, where he later succumbed ...
(Date:12/7/2016)... , ... December 07, 2016 , ... Castle Dermatology Institute ... several ways to restore a more youthful appearance to the face. Dr. Peyman Ghasri ... along with a variety of other treatments, to rejuvenate and renew the facial appearance. ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... Biosimilar Clinical Trial & Opportunity Insight" report by PNS Pharma gives comprehensive ... Currently 5 biosimilar version of Lantus are commercially available in ... , Czech Republic , Estonia , ... Slovakia , United Kingdom for the treatment ... in 2014. Lantus is the brand name for Insulin Glargine, a ...
(Date:12/7/2016)... Global Cervical Dysplasia Market: Scope and ... dysplasia market analyzes the current and future prospects ... executive summary, including a market snapshot that provides ... The research is a combination of primary and ... our research efforts along with information collected from ...
(Date:12/7/2016)... -- A new investigational drug originally developed for type 2 ... of the world,s first treatment to impede the progression of ... in the journal Science Translational Medicine . ... for millions of people living with Parkinson,s disease," says ... Research Institute,s Center for Neurodegenerative Science , chairman ...
Breaking Medicine Technology: